Fas and Fas ligand in human hepatocellular carcinoma

被引：7
|
作者：
Takehara, T [1 ]
Hayashi, N [1 ]
机构：
[1] Osaka Univ, Dept Mol Therapeut, Grad Sch Med, Suita, Osaka 5650871, Japan
来源：
JOURNAL OF GASTROENTEROLOGY | 2001年 / 36卷 / 10期
关键词：
D O I：
10.1007/s005350170040
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：727 / 728
页数：2
相关论文
共 50 条
  • [1] Fas and Fas ligand in human hepatocellular carcinoma
    Tetsuo Takehara
    Norio Hayashi
    Journal of Gastroenterology, 2001, 36 : 727 - 728
  • [2] Genetic mutation of Fas Fas ligand (Fas L) and its significance in hepatocellular carcinoma.
    Fukuzawa, Y
    Furuta, K
    Yoshida, K
    Itoh, M
    Sawada, T
    Tagaya, Y
    Ishikawa, T
    Kakumu, S
    Wada, K
    Omoto, Y
    HEPATOLOGY, 1999, 30 (04) : 542A - 542A
  • [3] Role of Fas ligand in immunopathogenesis of hepatocellular carcinoma
    Nakamoto, Y
    Kaneko, S
    Chisari, FV
    Suda, T
    Kobayashi, K
    GROWTH, PROLIFERATION, AND APOPTOSIS IN HEPATOCYTES, 2002, : 73 - 80
  • [4] Fas and Fas ligand as prognostic factors in human breast carcinoma
    Bebenek, Marek
    Dus, Danuta
    Kozlak, Joanna
    MEDICAL SCIENCE MONITOR, 2006, 12 (11): : CR457 - CR461
  • [5] The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma
    Hammam, Olfat
    Mahmoud, Ola
    Zahran, Manal
    Aly, Sohair
    Hosny, Karim
    Helmy, Amira
    Anas, Amgad
    HEPATITIS MONTHLY, 2012, 12 (11)
  • [6] The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
    Ito Y.
    Monden M.
    Takeda T.
    Eguchi H.
    Umeshita K.
    Nagano H.
    Nakamori S.
    Dono K.
    Sakon M.
    Nakamura M.
    Tsujimoto M.
    Nakahara M.
    Nakao K.
    Yokosaki Y.
    Matsuura N.
    British Journal of Cancer, 2000, 82 (6) : 1211 - 1217
  • [7] The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
    Ito, Y
    Monden, M
    Takeda, T
    Eguchi, H
    Umeshita, K
    Nagano, H
    Nakamori, S
    Dono, K
    Sakon, M
    Nakamura, M
    Tsujimoto, M
    Nakahara, M
    Nakao, K
    Yokosaki, Y
    Matsuura, N
    BRITISH JOURNAL OF CANCER, 2000, 82 (06) : 1211 - 1217
  • [8] Expression of Fas and Fas-related molecules in human hepatocellular carcinoma
    Lee, SH
    Shin, MS
    Lee, HS
    Bae, JH
    Lee, HK
    Kim, HS
    Kim, SY
    Jang, JJ
    Joo, M
    Kang, YK
    Park, WS
    Park, JY
    Oh, RR
    Han, SY
    Lee, JH
    Kim, SH
    Lee, JY
    Yoo, NJ
    HUMAN PATHOLOGY, 2001, 32 (03) : 250 - 256
  • [9] Expression of Fas-Fas ligand (Fas L) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma.
    Fukuzawa, Y
    Takahashi, K
    Furuta, K
    Tagaya, T
    Kakumu, S
    Koji, T
    HEPATOLOGY, 1998, 28 (04) : 361A - 361A
  • [10] Fas and Fas ligand expression in thyroid carcinoma
    Giannini, R
    Basolo, F
    LABORATORY INVESTIGATION, 2001, 81 (01) : 76A - 76A
12345